Drs Wallach and Rosenbaum discuss their study into the trends of IBD incidence among children in New York City during the COVID-19 pandemic, and their surprising findings.

In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk with Dr Peter Higgins from the University of Michigan about the etiology of inflammatory bowel disease, including what is and what is not known, the hygiene hypothesis, and the (possible) role of the family dog.

Dr Livanos discusses research she and colleagues conducted showing that a specific antigen may be detected up to 10 years before development of ulcerative colitis.

Dr Adam Faye elaborates on how antibiotic exposure puts adults aged 40 years and older at an increased risk for developing inflammatory bowel disease.

Adam Faye, MD, is an assistant professor of medicine and population health at the inflammatory bowel disease center at NYU Langone Health.

In this podcast, Dr Walter Chen sheds light on chronic gastrointestinal issues arising as a result of COVID-19 infection.

Brian Lacy, MD, is a professor of medicine and gastroenterologist at the Mayo Clinic in Jacksonville, Florida. Walter Chen, MD, is an associate professor of medicine in the division of gastroenterology and hepatology at the Brigham and Women’s Hospital in Boston, Massachusetts.

In this episode of IBD Drive Time, Dr Samir Shah talks with hosts Raymond Cross, MD, and Millie Long, MD, about his term as president of the American College of Gastroenterology and the addition of services to benefits both providers and patients as well as advances in IBD therapy and '80s music!

In this episode of IBD Drive Time, Dr Bharati Kochar, an expert in studying frailty in older patients, speaks about inflammatory bowel disease among older patients. Dr Kochar, Dr Ray Cross and Dr Millie Long also discuss considerations in medication to manage IBD in times of the ongoing COVID-19 pandemic.

In this episode of IBD Drive Time, Dr Bharati Kochar, an expert in studying frailty in older patients, speaks about inflammatory bowel disease among older patients. Dr Kochar, Dr Ray Cross and Dr Millie Long also discuss considerations in medication to manage IBD in times of the ongoing COVID-19 pandemic.

Millie Long, MD, is professor of medicine, vice-chief for Education and Fellowship Program director in the division of Gastroenterology and Hepatology at the University of North Carolina at Chapel Hill. Raymond Cross, MD, is professor of medicine and director of the Inflammatory Bowel Disease Program at the University of Maryland School of Medicine in Baltimore, Maryland. Bharati Kochar, MD, is a gastroenterologist and IBD specialist at Massachusetts General Hospital in Boston.

In this episode of IBD Drive Time, host Raymond Cross, MD, talks with Asher Kornbluth, MD, about choosing and monitoring therapies for inflammatory bowel disease from among the growing number of options.

Dr Mehandru reviews results of a study he and colleagues conducted at the Icahn School of Medicine in New York that examined the durability of response to p19 inhibitors among patients with IBD.